My friends,
Tiresias was considering talking about the other applications for in-vivo pathology, that is other than in neurosurgery, oral cancer and breast cancer. However, this week, the big news is in neurosurgery, so we will discuss neurosurgery again. Carl Zeiss have finally felt ready to come all out and start promoting the Convivo. Just this, the fact that Carl Zeiss the gold standard in microscopes for 160 years has come all out will their senior manager leading the promotion is a milestone. There is now no going back. If you have not seen this, Tiresias would strongly encourage you to have a look.
Teresa's had thought, and has written here, that there might be some initial resistance before penetration of in-vivo confocal laser endomicroscopy brain tumour surgery, and there might be an initial slow take-up. Viewing this hearing, and knowing that Carl Zeiss is behind this, Tiresias no longer considers that the uptake will be slow. Also, knows, that initial impression of Australian neurosurgeons, who viewed this, and who had not heard of Convivo before, as most neurosurgeons have not, this is actual working neurosurgeon; that this is absolutely a must have, now. With these two developments Tiresias now considers that the uptake in neurosurgery will be much faster, and Optiscan had better be ready for some big orders, and quick. You see, once one or two neurosurgical operating rooms have one of these there will be no possibility of anybody going into neurosurgery for tumour surgery not having in-vivo pathology. All tumour neurosurgery will need in-vivo pathology, once one or two have it, it becomes the standard of care. Who would have there child going in for brain surgery and the neurosurgeon not being able to see if there are malignant cells, if the neurosurgeon in the other hospital has the up to date technology which enables proper visualization of the tumour.
The other concept which Tiresias would like to introduce, for neurosurgery, as well as all other applications, is the likely future development on this initial product. You see, Tiresias is ancient. He was there at the introduction of modern neuro-imaging; the original CT scanners. He would like to point out that even the most forward-looking doctor, who saw the first CT scans, could not have foreseen the developments that neuro-imaging and interventional neuro-radiology. The same will happen in in-vivo pathology. Digital In-Vivo real-time histopathology is a platform technology, and nobody, not Zeiss, not Optiscan, not the neurosurgeons, not the pathologists, can foresee the ramifications and the developments that will occur. There are so many directions and so many potential changes and so many interventions that will be made possible that we cannot imagine, but they will be transformative. But as Tiresias has already said, neurosurgery is going to be but a small part of in-vivo microscopy in cancer treatment. This is revolutionary technology for cancer for the 21st-century. You definitely ain't seen nothing yet.
Add to My Watchlist
What is My Watchlist?
